Showing results (61-70 of 87) with videos related to
Sort By:
Pageof 9
Rheumatology (Oxford, England)|November 4, 2020
Consensus-based recommendations for the management of juvenile systemic sclerosisIvan Foeldvari, Roberta Culpo, Francesca Sperotto, et al.Expert Review of Pharmacoeconomics & Outcomes Research|November 27, 2020
Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare systemMichelle M A Kip, Sytze de Roock, Gillian Currie, et al.Rheumatology and Therapy|July 18, 2021
Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort StudyLuiza R Grazziotin, Gillian Currie, Marinka Twilt, et al.Nature Communications|May 29, 2026
Native long-read RNA sequencing of human monocytes reveals activation-induced alternative splicing toward functional isoformsAlejandra Bodelón, Maurice J H van Haaren, Paula Sobrevals Alcaraz, et al.Rheumatology (Oxford, England)|December 20, 2023
Quantifying hospital-associated costs, and accompanying travel costs and productivity losses, before and after withdrawing TNF-α inhibitors in juvenile idiopathic arthritisAnna A Florax, Martijn J H Doeleman, Sytze de Roock, et al.Pediatric Rheumatology Online Journal|July 11, 2023
Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists?Janine A van Til, Michelle M A Kip, Ellen J H Schatorjé, et al.Iscience|June 10, 2025
LIMK1 variants are associated with divergent endocrinological phenotypes and altered exocytosis dynamicsIrena J J Muffels, Theodore Carter, Holger Rehmann, et al.Pediatric Rheumatology Online Journal|July 23, 2022
Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritisLuiza R Grazziotin, Gillian Currie, Marinka Twilt, et al.Annals of the Rheumatic Diseases|March 4, 2019
Consensus-based recommendations for the management of juvenile localised sclerodermaFrancesco Zulian, Roberta Culpo, Francesca Sperotto, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2025
Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification CriteriaRemco G A Erkens, Greta Rogani, Laura Huber, et al.Pageof 9